WBIO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
WPD Pharmaceuticals, Inc. is a biotechnology research and development company, which engages in the research and development of medicinal products involving biological compounds and small molecules. Its products include WPD101, Berubicin, WP1066, WP1732, WPD102, WPD103, WP1220, and Annamycin. The company was founded on July 4, 2006 and is headquartered in Vancouver, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
WBIO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company